The American Diabetes Association believes no individual in need of insulin should ever go without it due to prohibitive costs. That is why we’re calling on all entities in the insulin supply chain to increase transparency and to ensure that no person with diabetes is denied affordable access to insulin. We’re also calling for Congress to hold hearings with all entities in the insulin supply chain to identify the reasons for the dramatic increases in insulin prices and to take action to ensure that all people who use insulin have affordable access to the insulin they need.

You can read more about our calls to action in our Resolution on Insulin Affordability and our Statement on Accessibility and Affordability of Diabetes Medications.